Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
Using Immunoassay technique to determine clinical efficacy of a biosimilar Filgrastim with reference Filgrastim
- At: 2017 FIP Congress in Stockholm (Sweden)
- Type: Poster
- By: ABOTALEB, Abdalla (Ministry of health, post marketing survillance, cairo, Egypt)
- Co-author(s): Nahla kotb: Lot release, NORCB, cairo, Egypt
Abdalla Abotaleb: post marketing survillance, NORCB, cairo, Egypt
Doaa Mohamed: Lot release, NORCB, cairo, Egypt
BackgroundsOver the next few years, the field of Biosimilars is expected to rapidly expand with the imminent patent expiry of a number of important biopharmaceuticals. Which raise a question
How regulatory body use a simple, accurate, effective technique to Guarantee safety and efficacy of Biosimilars products?
AimsConducting methods can help.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 4 October 2019